ArticleCancer management and research2025

Neoadjuvant Docetaxel-Carboplatin-Trastuzumab Therapy in HER2-Positive Breast Cancer: A Single-Center Experience from Vietnam.

Hung Nguyen Quang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.